Senescence-like changes induced by expression of p21Waf1/Cip1 in NIH3T3 cell line

Cell Research

Volumn 12, Issue 3-4, 2002, Pages 229-233

  Chen, Xi ^a   Zhang, Wei ^b   Gao, Yun Fei ^a   Su, Xiao Qin ^a   Zhai, Zhong He ^a  

^a PEKING UNIVERSITY   (China)

^b BEIJING NORMAL UNIVERSITY   (China)

Author keywords

Cell cycle arrest; Inducible expression; P21Waf1 Cip1; Senescence

Indexed keywords

MURINAE;

ANTIINFECTIVE AGENT; BETA GALACTOSIDASE; CDKN1A PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; DOXYCYCLINE;

ANIMAL; ARTICLE; CELL AGING; CELL CULTURE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL STRAIN 3T3; COMPARATIVE STUDY; DRUG EFFECT; GENE EXPRESSION; GENETIC TRANSDUCTION; GENETIC TRANSFORMATION; GENETICS; METABOLISM; MOUSE; PH; PHENOTYPE;

3T3 CELLS; ANIMALS; ANTI-BACTERIAL AGENTS; BETA-GALACTOSIDASE; CELL AGING; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DOXYCYCLINE; G1 PHASE; GENE EXPRESSION; HYDROGEN-ION CONCENTRATION; MICE; PHENOTYPE; S PHASE; TRANSDUCTION, GENETIC; TRANSFORMATION, GENETIC;

EID: 0036725992     PISSN: 10010602     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cr.7290129     Document Type: Article

References (17)

1. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G (1)-phase progression. Genes and Development 1999; 13(12):1501-12.
2. El-Deiry WS, Tokino T, Velculescu VE et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75(4):817-25.
3. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 CDK interacting protein CIP1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993; 75 (4):805-16.
4. Waga S, Hannon GJ, Beach D, Stillman B. The p21 inhibitor of cyclin-dependent kinases controls DNA-replication by interaction with PCNA. Nature 1994; 369 (6481):574-8.
5. Noda A, Ning Y, Venable SF, Pereirasmith OM, Smith JR. Cloning of senescent cell-derived inhibitors of DNA-synthesis using an expression screen. Exper Cell Res 1994; 211(1):90-8.
6. Brown JP, Wei WY, Sedivy JM. Bypass of senescence after disruption of p21 (CIP1/WAF1) gene in normal diploid human fibroblasts. Science 1997; 277(5327):831-4.
7. (Waf1/Cip1/Sdi1) on cellular gene expression: Implications for carcinogenesis, senescence, and age-related diseases. Proc Natl Acad of Sci USA 2000; 97(8):4291-6.
8. (Waf1/Cip1/Sdi1) induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53. Oncogene 1999; 18(18):2789-97.
9. (waf) expression in H1299 cell line promotes cell senescence and protects against cytotoxic effect of radiation and doxorubicin. Oncogene 1999; 18:2643-9.
10. Pantoja C, Serrano M. Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras. Oncogene 1999; 18(35):4974-82.
11. (Waf1/Cip1). Molecular Carcinogenesis 2001; 32 (1):9-18.
12. Medcalf ASC, KleinSzanto AJP, Cristofalo VJ. Expression of p21 is not required for senescence of human fibroblasts. Cancer Research 1996; 56(20):4582-5.
13. (INK4a). Cell 1997; 88(5):593-602.
14. Rossi FMV, Guicherit OM, Spicher A et al. Tetracycline-regulatable factors with distinct dimerization domains allow reversible growth inhibition by p16. Nature Genetics 1998; 20(4):389-93.
15. Dimri GP, Lee X, Basile G et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995; 92:9363-7.
16. Ramirez RD, Morales CP, Herbert BS et al. Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. Genes and Development 2001; 15(4):398-403.
17. Wright WE, Shay JW. Cellular senescence as a tumor-protection mechanism: the essential role of counting. Current Opinion in Genetics and Development 2001; 11:98-103.